Repligen Corporation (RGEN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 164.89 |
| Open | 164.70 |
| Bid | 166.53 x 100 |
| Ask | 167.00 x 200 |
| Day's range | 163.82 - 167.43 |
| 52-week range | 110.45 - 211.13 |
| Volume | |
| Avg. volume | 497,462 |
| Market cap | 9.321B |
| Beta (5Y monthly) | 1.03 |
| PE ratio (TTM) | 641.58 |
| EPS (TTM) | 0.26 |
| Earnings date | 31 July 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 204.58 |
Simply Wall St.We Discuss Why Repligen Corporation's (NASDAQ:RGEN) CEO Compensation May Be Closely Reviewed
Key Insights Repligen will host its Annual General Meeting on 16th of May CEO Tony Hunt's total compensation includes...
GlobeNewswireRepligen Corporation to Present at Upcoming May Investor Conferences
WALTHAM, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participating at the following May investor conferences. RBC Capital Markets’ 2024 Global Healthcare Conference, being held in New York on May 14-15. Jason K. Garland, Chief Financial Officer, is scheduled to participate in an analyst-led discussion on May 14, 2024 at 10:30 a.m. ET, in addition to a series of
Simply Wall St.Repligen First Quarter 2024 Earnings: EPS Misses Expectations
Repligen ( NASDAQ:RGEN ) First Quarter 2024 Results Key Financial Results Revenue: US$151.3m (down 17% from 1Q 2023...
© 2024 Yahoo. All rights reserved.